中美部分高校药学专业科研论文产出情况对比分析  

Comparative analysis of scholarly treatise outputs in pharmaceutical sciences in top 10 universities between China and the USA

作　　者：兰芬[1] 魏雯婕[2] 阳凌燕[1] 李睿旻[3] 胡晋红[1] 

机构地区：[1]第二军医大学长海医院药学部,上海200433 [2]同济大学图书馆,上海200092 [3]第二军医大学药学院药事管理与临床药学教研室,上海200433

出　　处：《药学服务与研究》2016年第6期468-472,共5页Pharmaceutical Care and Research

摘　　要：目的:比较分析中国和美国排名前十位高校的药学专业科研论文产出情况,以期为国内药学研究者提供建议。方法:检索Scopus数据库中国和美国药学专业排名前十位高校的药学研究论文,用SciVal做文献计量分析。结果:两国高校的药学科研论文数量无显著性差异,被引频次前1%和10%论文占比、在前10%和前25%期刊发表的论文占比、篇均被引频次、域加权引用影响因子(FWCI)、产学合作论文占比、被专利引用的论文占比均有显著性差异(P<0.01)。结论:国内高校药学专业科研论文产出量与美国高校无显著差异,但论文质量指标尚存差距。建议国内高校药学研究者加强产学合作、机构间合作以及国际合作。Objective： To compare the scholarly treatise outputs of pharmaceutical sciences between top 10 universities in China and the USA,so as to provide reference for domestic pharmaceutical researchers. Methods： All the scholarly publications in pharmaceutical sciences produced by top 10 universities in China and the USA from 2005 to 2015 were retrieved from Seopus database,and then analyzed on the platform of SciVal. Results： Publication counts were not significantly different between China and USA. However, publications percentage in top 1% and 10% most cited papers, in top 10% and 25% journals, fieldweighted citation impact, citations per publication, academic-corporate collaboration ratio and patent-cited publication ratio were significantly different（P〈0.01）. Conelusion; The quantity of pharmaceutical scholarly treatise outputs of China was not significantly different from that of the USA, while the quality bibliometric indexes of China still lagged behind. It was suggested that pharmaceutical researchers in universities in China should further expand their academic-corporate, interinstitutional and international collaborations.

关 键 词：高校 药学 药学文献分析 文献计量学 

分 类 号：R9-14[医药卫生—药学]